OMX30 1 580 0,4%  OMXH25 3 768 0,2%  OMXC20 908 0,6%  Dow 20 702 0,7%  Nas 5 407 0,6%  EUR 9,5463 0,0%  USD 8,8284 0,5%  Olja 51,3 1,0%  Guld 1 251 -0,5% 

Johnson & Johnson Aktie

125,65USD -0,14USD -0,11%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Johnson & Johnson

2016 2017e 2018e 2019e 2020e
Utdelning 3,15 3,35 3,55 3,77 3,86
Direktavkastning (i %) 2,71 2,63 2,80 2,97 3,04
PE-tal 17,24 18,00 17,08 16,17 15,23
Resultat/aktie 6,73 7,05 7,44 7,85 8,34
ytterligare nyheter

Analyser om Johnson & Johnson

Jun, 13 2016 Johnson & Johnson Neutral Goldman Sachs Group Inc.
ytterligare analyser

Johnson & Johnson Peer Group

Abbott Laboratories 44,70
0,0%
Alexion Pharmaceuticals 118,52
-0,3%
AstraZeneca 552,00
-0,5%
Bayer 106,90
0,3%
Beiersdorf 88,54
0,5%
Celgene 124,44
-0,5%
Fresenius Medical Care 78,06
1,0%
Fresenius 73,90
1,0%
GlaxoSmithKline 16,77
0,0%
Johnson & Johnson 125,65
-0,1%
Merck 63,33
0,2%
Merck 103,80
0,6%
MorphoSys 54,47
3,6%
Nestle SA 77,05
-0,5%
Novartis 73,75
-0,1%
Pfizer 34,17
-0,1%
Procter & Gamble 90,77
0,3%
Roche 253,00
0,1%
STADA Arzneimittel 57,10
2,2%
Sanofi 83,94
0,6%
Unilever 46,50
-0,4%
pagehit

Lägg till instrument

Vad tycker du?

Profil Johnson & Johnson

till bolagsprofilen
Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Realtidskurs Johnson & Johnson

Bid
124,04
USD
Ask
126,77
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Johnson & Johnson i USDPUSH CHART

Kurs 125,65 USD -0,14 -0,11 %
Kurstid 21:59:58
Datum 28.03.2017
Öppning 125,54
Gårdagen 125,79
Dagshögsta 125,76
Dagslägsta 124,79
52 v. högsta 129,00
52 v. lägsta 107,71
52 v. perf.
Volym (Antal) 351 979
Börsvärde (SEK) 2 998,29 Mrd
Börsen
Kurs för 125,65 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 109,29 SEK.

Till aktien Johnson & Johnson

Ticker
ISIN US4781601046
Index Dow Jones, S&P 100, NYSE US 100, BX Swiss - USA, S&P 500

Struktuerarde produkter på Johnson & Johnson

Produkttyp Antal
Plain Vanilla Warrants 1
Certificates 2

Johnson & Johnson Nyckeltal

Börsvärde i SEK 2 998,29 Mrd
Free float % 99,90
Antal aktier mio. 2 710,89
Cashflow/aktie i lokal valuta 6,47
Bokvärde/aktie i lokal valuta 27,40
60 dagar vola 13,56
PBV 4,24

Johnson & Johnson Historiska kurser

2017-03-27 125,79 343 735
2017-03-24 125,46 463 589
2017-03-23 125,89 844 385
2017-03-22 126,25 856 113
2017-03-21 127,26 524 310

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 698,9 %
Exelixis Inc. 468,7 %
EXACT Sciences Corp. 280,5 %
Amylin Pharmaceuticals Inc. 264,9 %
Ariad Pharmaceuticals Inc. 260,2 %